In this video, Charles Gore, Executive Director of the Medicines Patent Pool, shares the vital work MPP does and why they need your support to continue their mission.

He explains how MPP, founded by Unitaid in 2010, has been dedicated to expanding access to essential medicines and health technologies in low- and middle-income countries. Through negotiating voluntary licences with pharmaceutical companies, MPP enables the production of affordable, quality-assured generic medicines, delivering over 43 billion treatment doses in 148 countries and saving the global health community 1.9 billion US dollars. Charles highlights the ongoing challenge that nearly 2 billion people in low- and middle-income countries still lack access to necessary medicines, which not only causes individual suffering but also undermines global health security and economic prosperity. He emphasises that MPP’s voluntary licensing model creates a win-win situation for originator companies, generic manufacturers, and people in need, fostering healthy competition that drives down prices and expands supply.

He calls for partners and financial supporters to join MPP in making a difference, scaling their impact, and ensuring that scientific breakthroughs reach those who need them most. Together, we can achieve a more resilient, equitable global health system.